Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines

World Journal of Urology

Volumn 19, Issue 5, 2001, Pages 365-370

  Grossmann, Michael E ^a   Wood, Monique ^b   Celis, Esteban ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CARBOXYPEPTIDASE; GLUTAMATE CARBOXYPEPTIDASE II; HOMEODOMAIN PROTEIN; HOXB 13 PROTEIN; HOXB-13 PROTEIN; MEMBRANE PROTEIN; NKX 3.1 PROTEIN; NKX-3.1 PROTEIN; PROSTATE STEM CELL ANTIGEN; PROSTATIC SECRETORY PROTEIN; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR; TUMOR ANTIGEN; TUMOR PROTEIN;

ADENOCARCINOMA; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; IN VITRO STUDY; MALE; MOUSE; PHYSIOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; CARBOXYPEPTIDASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; IMMUNOTHERAPY; IN VITRO; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035512419     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007104     Document Type: Article

References (19)

1. 1. Wingo PA, Landis S, Parker S, Bolden S. Heath CW (1998) Using cancer registry and vital statistics data to estimate the number of new cancer cases and deaths in the Unites States for the upcoming year. J Reg Management 25: 43 51
2. Dawson NA, Vogelzang NJ (1994) Prostate cancer. Wiley-Liss, New York
3. Rosenberg SA (1997) Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 18: 175
4. Mortarelli EA (1992) Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer. Ann Clin Lab Sei 22: 201
5. Cooper EH, Robinson MR, Whelam P, Ferro MA (1992) Tumor markers in prostate cancer. Cancer 70: 225
6. Myers RB, Grizzle WE (1996) Biomarker expression in prostatic intraepithelial neoplasia. Eur Urol 30: 153
7. Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A (1994) Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl 162: 73
8. Israeli RS, Powell CT, Fair WR, Hesto WDW (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53: 227-230
9. Prescott JL, Blok L, Tindall DJ (1998) Isolation and androgen regulation of the human homeobox cDNA, NK.X3.1. Prostate 35: 71 80
10. Greenburg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ. Rosen JM (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sei USA 92: 3439-3443
11. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelpoulou R, Rosen JM, Greenburg NM (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096-4102
12. Gingrich JR, Barrios FJ, Kattan MW, Nahm HS, Finegold MJ, Greenburg N M (1997) Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57: 4687-4691
13. Foster BA, Gingrich JR, Kwon ED, Madias C, Greenber NM (1997) Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 57: 3325-3330
14. Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenburg NM, Burg MB, Allison JP (1997) Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc Natl Acad Sei USA 94: 80998103
15. Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A (1997) Derivation of HLA-A1 I/Kb transgenic mice: functional CTL repertoire and recognition of human Al 1-restricted CTL epitopes [published erratum appears in J Immunol 1999 162(5): 3104]. J Immunol 159: 4753-4761
16. Wang R F, Rosenberg SA (1999) Human tumor antigens for cancer vaccine development. Immunol Rev 170: 85-100
17. Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM (1994) Induction of antitumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sei USA 91: 2105
18. Vesalainen S, Lipponen P, Talja M, Syrjanen K (1994) Histological grade, perineural infiltration, tumor-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A: 1797-1803
19. Doherty PC, Allan W, Eichelberger M, Carding SR (1992) Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu Rev Immunol 10: 123-151